English Su hija de casi seis años quiere que le hornee un elaborado pastel o torta de cumpleaños en la forma de un castillo de cuento de hadas, con arcoíris, unicornios y una princesa para su fiesta. Encontró un video de decoración de pasteles en línea, pero necesita ingredientes que le hacen preguntarse si es…
Vi-Jon, LLC Expands Voluntary Nationwide Recall of All Flavors and Lots Within Expiry of Magnesium Citrate Saline Laxative Oral Solution Due to Microbial Contamination
Summary Company Announcement Date: July 25, 2022 FDA Publish Date: July 26, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential Gluconacetobacter liquefaciens contamination Company Name: Vi-Jon, LLC Brand Name: Brand Name(s) Multiple Brands Product Description: Product Description Magnesium Citrate Saline Laxative Oral Solution Company Announcement FOR IMMEDIATE RELEASE – July 25, 2022…
La función fundamental de la FDA para garantizar el suministro de vacunas contra la influenza
Image English La vacuna contra la gripe que recibe en el consultorio de su médico o la farmacia es producto del trabajo que realizan durante todo el año microbiólogos, epidemiólogos, médicos y otros expertos en salud pública altamente especializados. ¿Suena complicado? Lo es. La Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por…
FDA D.I.S.C.O. Burst Edition: FDA approval of Tafinlar (dabrafenib) in combination with Mekinist (trametinib) for unresectable or metastatic solid tumors with BRAF V600E mutation
Podcast Welcome back to the D.I.S.C.O., FDA’s Drug Information Soundcast in Clinical Oncology, Burst Edition, brought to you by FDA’s Division of Drug Information in partnership with FDA’s Oncology Center of Excellence. Today we’ll provide another quick update on a recent FDA cancer drug approval. On June 22, 2022, the FDA granted accelerated approval to…
Ultra Supplement LLC Issues Voluntary Nationwide Recall of Sustango Due to the Presence of Undeclared Tadalafil
Summary Company Announcement Date: July 21, 2022 FDA Publish Date: July 25, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Undeclared Tadalafil Company Name: Ultra Supplement LLC Brand Name: Brand Name(s) Product Description: Product Description Dietary Supplement for Male Enhancement Company Announcement FOR IMMEDIATE RELEASE – 7/21/22 – Wilmington DE, Ultra Supplement LLC…
Voluntary Recall of Certain Over-the-Counter Products
Summary Company Announcement Date: July 21, 2022 FDA Publish Date: July 21, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Products stored outside of temperature requirements Company Name: Family Dollar Brand Name: Brand Name(s) Multiple brands Product Description: Product Description Multiple OTC Medical Products Company Announcement Family Dollar is initiating a voluntary retail…
FDA D.I.S.C.O. Burst Edition: FDA approval of Breyanzi (lisocabtagene maraleucel) for second-line treatment of large B-cell lymphoma
Podcast Welcome back to the D.I.S.C.O., FDA’s Drug Information Soundcast in Clinical Oncology, Burst Edition, brought to you by FDA’s Division of Drug Information in partnership with FDA’s Oncology Center of Excellence. Today we’ll provide another quick update on a recent FDA cancer drug approval. On June 24, 2022, the FDA approved lisocabtagene maraleucel (brand…
UPDATE: Use of Renuvion/J-Plasma Device for Certain Aesthetic Procedures: FDA Safety Communication
Date Issued: July 21, 2022 The U.S. Food and Drug Administration (FDA) is providing another update on the Renuvion/J-Plasma device system by Apyx Medical about use of the device for certain aesthetic skin procedures. In March 2022, the FDA warned against the use of Renuvion/J-Plasma for procedures intended to improve the appearance of the skin…
Want to Quit Smoking? FDA-Approved and FDA-Cleared Cessation Products Can Help
Image Español How to Choose a Smoking Cessation Product That’s Right for You Smoking cessation products approved or cleared by the U.S. Food and Drug Administration are shown to help people quit smoking and can even double your chance of quitting successfully. Are you or a loved one among those American adults who smoke cigarettes…
Smiths Medical Recalls Certain Medfusion 3500 and 4000 Syringe Infusion Pumps for Software Issues That May Impact Infusion Delivery
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product Product Name: Medfusion Syringe Infusion Pumps Models, Product Codes, and Software Versions: See Recall Database Entries Devices Recalled in the U.S.: 118,055 Dates distributed: October 2004 to…